Pacira BioSciences Inc’s filing revealed that its Chief Operating Officer GAUGLER DARYL unloaded Company’s shares for reported $6430.0 on Sep 13 ’24. In the deal valued at $12.86 per share,500 shares were sold. As a result of this transaction, GAUGLER DARYL now holds 115,700 shares worth roughly $1.93 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, GAUGLER DARYL bought 500 shares, generating $6,430 in total proceeds.
Before that, BIGAL MARCELO bought 1,512 shares. Pacira BioSciences Inc shares valued at $20,034 were divested by the Director at a price of $13.25 per share. As a result of the transaction, BIGAL MARCELO now holds 10,142 shares, worth roughly $0.17 million.
Truist downgraded its Pacira BioSciences Inc [PCRX] rating to a Sell from a a Buy in a research note published on August 13, 2024; the price target was decreased to $8 from $30. A number of analysts have revised their coverage, including RBC Capital Mkts’s analysts, who decreased its forecast for the stock in mid August from “an Outperform” to “a Sector perform”. Raymond James also remained covering PCRX and has decreased its forecast on August 12, 2024 with a “Mkt perform” recommendation from previously “an Outperform” rating. Piper Sandler revised its rating on August 12, 2024. It rated PCRX as “a Neutral” which previously was an “an Overweight”.
Price Performance Review of PCRX
On Tuesday, Pacira BioSciences Inc [NASDAQ:PCRX] saw its stock fall -6.34% to $16.68. Over the last five days, the stock has lost -4.25%. Pacira BioSciences Inc shares have fallen nearly -50.56% since the year began. Nevertheless, the stocks have fallen -40.02% over the past one year. While a 52-week high of $35.95 was reached on 01/08/24, a 52-week low of $11.16 was recorded on 08/13/24. SMA at 50 days reached $16.53, while 200 days put it at $22.37.
Levels Of Support And Resistance For PCRX Stock
The 24-hour chart illustrates a support level at 16.08, which if violated will result in even more drops to 15.48. On the upside, there is a resistance level at 17.61. A further resistance level may holdings at 18.54. The Relative Strength Index (RSI) on the 14-day chart is 47.81, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.21, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 67.39%. Stochastics %K at 54.36% indicates the stock is a holding.
How much short interest is there in Pacira BioSciences Inc?
A steep rise in short interest was recorded in Pacira BioSciences Inc stocks on 2024-11-15, dropping by -1.32 million shares to a total of 4.82 million shares. Yahoo Finance data shows the prior-month short interest on 2024-10-15 was 6.14 million shares. There was a decline of -27.34%, which implies that there is a negative sentiment for the stock.
